Mode
Text Size
Log in / Sign up

Blastomycosis

Part of Fungal infection

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Blastomycosis

2 trials tracked for Blastomycosis: 2 in phase 3 or 4.

2Trials tracked
2Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 2
  1. Phase 3 Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment Completed
  2. Phase 3 A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about Blastomycosis

What does the 2019 surveillance report say about blastomycosis in the US?

The 2019 surveillance report documents the number of blastomycosis cases in the United States, noting that these infections are often found alongside other fungal diseases like histoplasmosis and coccidioidomycosis.

Full answer →
Why did blastomycosis cases increase in some areas during the pandemic?

Blastomycosis cases increased during the pandemic because people spent more time outdoors and in areas with damp soil, which releases the fungus into the air.

Full answer →
Are there more blastomycosis cases now compared to before the pandemic?

Data from 2019 and during the pandemic show that blastomycosis cases did not increase significantly compared to pre-pandemic levels.

Full answer →